Follow-up reply to Members of the European Parliament regarding mRNA COVID-19 vaccines
Human medicines European public assessment report (EPAR): Dimethyl fumarate Polpharma, dimethyl fumarate, Date of authorisation: 13/05/2022, Revision: 5, Status: Withdrawn
Vaxzevria: Periodic safety update report assessment 29 June 2022 to 28 December 2022
Spikevax : Periodic safety update report assessment 19 June 2022 to 17 December 2022
EudraVigilance training and support
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 3 June 2024 to 7 June 2024
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 13 May 2024 to 17 May 2024
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 15 April 2024 to 19 April 2024
Mandatory use of ISO/ICH E2B(R3) individual case safety reporting in the EU: hands-on training course using the EudraVigilance system, Online, from 4 March 2024 to 8 March 2024
Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG), Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 November 2023, 10:00 (CET) to 23 November 2023, 12:00 (CET)